Foci formation assays also demonstrated that HCC cell lines with a high percentage of CD133+ cells had a stronger resistance than did HCC cell lines with a low percentage of CD133+ cells (Fig. 2c). This evidence concerns the gene PROM1 and hepatocellular carcinoma.